Clinical relevance of inhaled corticosteroids and HPA axis suppression

Slides:



Advertisements
Similar presentations
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.
Advertisements

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered- dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder.
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Shin-Ichi Nishikawa, MD, PhD 
David B Allen, MD  Journal of Allergy and Clinical Immunology 
Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations  Peter G. Gibson, MBBS(Hons),
Christine A. Sorkness, PharmD 
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis  William R. Lumry, MD  Journal of.
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.
Asthma diagnosis and treatment: Filling in the information gaps
Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,
Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
Practice Notes from the AAAI
David P. Skoner, MD, Betty L
Badrul A. Chowdhury, MD, PhD 
Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis  Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,
Elephantiasis nostras: A case report
Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with.
Conjunctivitis medicamentosa
Peter M. Wolfgram, MD, David B. Allen, MD 
Side effects of inhaled corticosteroids
Inhaled corticosteroids: Impact on asthma morbidity and mortality
Michael Mellon, MD  Journal of Allergy and Clinical Immunology 
Practice Notes from the AAAAI
Increased sensitivity to bradykinin among African Americans
H.William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Paul M. O’Byrne, MB, FRCPI, FRCP(C)a, Soren Pedersen, MD, PhDb 
A review of the current guidelines for allergic rhinitis and asthma
Physician-targeted program on inhaled therapy for childhood asthma
News & Notes Journal of Allergy and Clinical Immunology
Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization  Qutayba Hamid, MD, PhD, Editor  Journal.
Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled.
New devices for asthma Journal of Allergy and Clinical Immunology
Effect of β-adrenergic agonists on mucociliary clearance
Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma  Mamert Milewski, MD, Lucyna Mastalerz, MD, Ewa Niżankowska, MD, Andrzej.
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma  William.
Clinical need for a nebulized corticosteroid
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients.
Autophagy: Nobel Prize 2016 and allergy and asthma research
A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma  Gordon D. Raphael, MDa, Robert.
News & Notes Journal of Allergy and Clinical Immunology
Fluticasone propionate powder: Oral corticosteroid–sparing effect and improved lung function and quality of life in patients with severe chronic asthma 
Observations on emerging patterns of asthma in our society
Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma  Michael Schatz, MD, MSa, E.Francis Cook, DScb, Randy Nakahiro,
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered- dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder.
Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled.
The role and remediation of animal allergens in allergic diseases
Preparing patients and health professionals for the transition to chlorofluorocarbon-free inhalers: The British perspective  Helen Donohoe, MSc (Econ) 
Inhaled β2 -agonists and airway responses to allergen
Practice Notes from the AAAI
Determinants of systemic manifestations of food allergy
Robert P. Schleimer, PhD  Journal of Allergy and Clinical Immunology 
Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma  Sally E. Wenzel, MD  Journal of Allergy and Clinical.
Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy  Diane J. Pincus, MD, Teresa R. Humeston,
Challenges in assessing outcomes for pediatric asthma
Footnotes1 Journal of Allergy and Clinical Immunology
National trends in asthma visits and asthma pharmacotherapy,
David P. Skoner, MD  Journal of Allergy and Clinical Immunology 
Evelyn Farinas, RPh, MGA, Peter Honig, MD 
The preventive effect and duration of action of two doses of inhaled furosemide on exercise-induced asthma in children  Elio Novembre, MD, Gianfranco.
News & Notes Journal of Allergy and Clinical Immunology
Normal diurnal variation in serum cortisol concentration in asthmatic children treated with inhaled budesonide  Benjamin Volovitz, MD, Arieh Kauschansky,
Desloratadine: A new, nonsedating, oral antihistamine
Presentation transcript:

Clinical relevance of inhaled corticosteroids and HPA axis suppression Robert G. Dluhy, MD  Journal of Allergy and Clinical Immunology  Volume 101, Issue 4, Pages S447-S450 (April 1998) DOI: 10.1016/S0091-6749(98)70157-5 Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 1 Effect of budesonide (800 μg once daily),placebo, and fluticasone propionate (>FP; 250, 500, and 1000 μg once daily; 1000 μg twice daily) on 8-hour plasma cortisol levels in healthy volunteers. Reproduced with permission from Grahnen A. Eckermas SA, Brundin RM, Ling-Anderson A. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 1994;38:521-5, by Blackwell Science Ltd.). Journal of Allergy and Clinical Immunology 1998 101, S447-S450DOI: (10.1016/S0091-6749(98)70157-5) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 2 Effect of placebo, fluticasone propionate (FP; 100 and 500 μg twice daily), triamcinolone acetonide (TAA; 300 and 500 μg twice daily), and prednisone (Pred; 10 mg daily) on plasma cortisol levels in asthma patients (data on file, Glaxo Wellcome). Journal of Allergy and Clinical Immunology 1998 101, S447-S450DOI: (10.1016/S0091-6749(98)70157-5) Copyright © 1998 Mosby, Inc. Terms and Conditions